Decrease in mean visual analogue score (VAS) for pain and analgesics used at 1 and 3 months after percutaneous vertebroplasty (PV) in patients with vertebral compression fractures (VCF) with absent bone marrow edema (no BME) prior to PV and patients with full BME (full BME) in treated VCF
| Follow-up Period after PV | ||||
|---|---|---|---|---|
| 1 Month | 3 Months | |||
| Mean Decrease VAS | Mean Decrease Analgesics | Mean Decrease VAS | Mean Decrease Analgesics | |
| No BME | 5.1 | 43% | 0.4 | 0% |
| Full BME | 5.8 | 84% | 0.5 | 13% |
| Regression coefficient | .7 | .9 | .09 | .07 |
| 99% Confidence interval | −1–2.4 | 0.1–1.7 | −0.7–0.9 | −0.4–0.5 |